Clinical Trial Update: A Study of 1 8F-FDHT PET/MRIScans in Women With Breast Cancer [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 study evaluating 18F-FDHT PET/MRI scans in women with breast cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 18F-FDHT PET/MRI tracer (18F-FDHT)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer, Breast Carcinoma | EARLY_Phase 1 | Status: WITHDRAWN